The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis

The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis

Introduction: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have an extremely important impact on the treatment of hormone-sensitive breast cancer (BC) and have radically changed the first-line treatment for metastatic disease with increased rates of treatment response, overall survival (OS), and...

Full description

Bibliographic Details
Main Authors: Fausto Petrelli, Lorenzo Dottorini, Giandomenico Di Menna, Karen Borgonovo, Maria Chiara Parati, Carmen Giusy Rea, Mara Ghilardi, Antonio Ghidini, Andrea Luciani
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Breast
Subjects:
Breast cancer
Elderly
CDK4/6 inhibitors
Metastatic disease
Meta-analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977623004599

Internet

http://www.sciencedirect.com/science/article/pii/S0960977623004599

Similar Items